Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | STOK | RAPP | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Stoke Therapeutics Inc | Rapport Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.44 | 31.93 | 39.06 | ||
| High | 3.68 | 31.94 | 39.69 | ||
| Low | 3.35 | 30.66 | 38.14 | ||
| Latest | 3.59 | 30.91 | 39.50 | ||
| Change | +0.15 | -0.70 | +0.01 | ||
| % Change | +4.36% | -2.21% | +0.03% | ||
| Volume | 29,983,500 | 543,700 | 345,600 | ||
| 20-Day Average Volume | 17,027,551 | 557,275 | 323,835 | ||
| Previous Close | 3.44 | 31.61 | 39.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.19 | 31.54 | 37.34 | ||
| 20-Day Raw Stochastic | 90.11% | 40.03% | 83.67% | ||
| 20-Day Relative Strength | 57.25 | 44.83 | 60.34 | ||
| Weighted Alpha | -25.07 | +136.36 | +156.94 | ||
| Today's Opinion | 56% Sell | 8% Sell | 100% Buy | ||
| Previous Opinion | 64% Sell | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 72% Sell | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.43% since 05/21/26 | +4.18% since 05/21/26 | +7.63% since 05/21/26 | ||
| Low | 2.90 on 05/27/26 | 29.22 on 05/22/26 | 36.38 on 05/22/26 | ||
| High | 3.68 on 05/29/26 | 32.35 on 05/27/26 | 40.72 on 05/27/26 | ||
| 1-Month | |||||
| %Chg | +8.79% since 04/29/26 | -4.66% since 04/29/26 | +19.70% since 04/29/26 | ||
| Low | 2.77 on 05/19/26 | 28.02 on 05/19/26 | 32.41 on 04/30/26 | ||
| High | 3.68 on 05/29/26 | 35.24 on 05/05/26 | 40.80 on 05/08/26 | ||
| 3-Month | |||||
| %Chg | -2.18% since 02/27/26 | -15.11% since 02/27/26 | +36.07% since 02/27/26 | ||
| Low | 2.77 on 05/19/26 | 28.02 on 05/19/26 | 26.01 on 03/19/26 | ||
| High | 3.90 on 04/16/26 | 40.22 on 03/10/26 | 40.92 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | -22.46% since 11/28/25 | unch since 11/28/25 | +32.95% since 11/28/25 | ||
| Low | 2.77 on 05/19/26 | 25.21 on 01/12/26 | 25.21 on 02/05/26 | ||
| High | 5.24 on 01/22/26 | 40.22 on 03/10/26 | 40.92 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,902,359 | 1,925,137 | 1,889,166 | ||
| Shares Outstanding, K | 529,905 | 62,282 | 47,827 | ||
| Annual Sales | 74,680,000 | 184,420,000 | 0 | ||
| Annual Net Income | -644,760,000 | -6,890,000 | -111,480,000 | ||
| Last Quarter Sales | 6,470,000 | 6,230,000 | 20,000,000 | ||
| Last Quarter Net Income | -117,500,000 | -50,000,000 | -19,860,000 | ||
| 60-Month Beta | 1.05 | 1.20 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/06/26 | -0.79 on 05/07/26 | -0.42 on 05/07/26 | ||
| Earnings Date | 08/04/26 | 08/11/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||